This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
27 Oct 2011

GSK Reports Q3 Results with 7 Percent Rise in Profit

GSK said underlying sales were up 57 percent in Japan and 11 percent in emerging markets, while sales were up just 1 percent in the U.S., the company's biggest market, and down 4 percent in Europe.

UK's drug maker GlaxoSmithKline announced a 7 percent rise in profit in the third quarter, in line with market forecasts.

 

The company reported Wednesday that net profit grew to 1.38 billion pounds ($2.2 billion) compared to 1.29 billion pounds a year earlier. Revenue rose 4.3 percent to 7.1 billion pounds.

 

GSK said underlying sales were up 57 percent in Japan and 11 percent in emerging markets, while sales were up just 1 percent in the U.S., the company's biggest market, and down 4 percent in Europe.

 

The sales surge in Japan was led by GSK's cervical cancer vaccine Cervarix, which is being used in a national vaccinatio

Related News